FADS1 serves as a candidate shared biomarker for metabolic dysfunction‑associated steatohepatitis related early‑onset colorectal cancer identified via machine learning and in vitro validation
Abstract Newest evidence shows a link between early-onset colorectal cancer (EO-CRC) and metabolic dysfunction-associated steatohepatitis (MASH). The molecular mechanism behind this connection is not clear. This study tries to find key biomarkers linked to the progression and treatment response of MASH-associated EO-CRC. Differential expression analysis (DEGs) and weighted gene co-expression network analysis (WGCNA) were performed to mine associated genes. Forty-four machine learning algorithms were used to screen candidate biomarkers. For the purpose of pinpointing critical biomarkers, this study, integrating survival analysis, expression profiling, and prognostic assessment, was carried out. Through the application of single-cell RNA sequencing (scRNA-seq) data and in vitro experimental approaches, verification, of gene expression and functional roles, was achieved. With the edgeR package and WGCNA, coexpressed genes enriched in matrix remodeling and lipid metabolism pathways are obtained, and seven candidate biomarkers are selected by machine learning, among which only FADS1 connects to disease prognosis and advanced stage. scRNA-seq and virtual knockout experiments revealed that FADS1 in tumor cells is associated with fibrosis and angiogenesis. Further validation using quantitative real-time PCR (qRT-PCR), Western blotting and immunohistochemistry (IHC) staining identified FADS1 as a candidate shared biomarker, offering a promising theoretical basis for fundamental tumor research and clinical translational applications.
Authors
- Yingdong Hou (ORCID: https://orcid.org/0009-0003-7692-332X)
- Xuepei Zhang (ORCID: https://orcid.org/0000-0003-0919-5871)
- Yifeng Zhou (ORCID: https://orcid.org/0009-0008-3550-2349)
- Xiangyun He
- Hubin Xia
- Qianli Yu
Institutions
- Zhejiang Chinese Medical University (CN)
- Westlake University (CN)
- Zhejiang Cancer Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1007/s12672-026-06235-y
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00